Highlights
- •Bariatric surgery reduces the risk of follow-up overall coronary revascularization
- •Future CABG and PCI risks are reduced in the metabolic surgery cohort
- •Less revascularization is observed in bypass compared to gastric banding
Abstract
Background
Metabolic surgery is associated with improved cardiovascular risk profile. Randomized
and observational studies exploring the impact of bariatric surgery on follow-up coronary
revascularization (CR) as a primary endpoint are limited.
Objectives
To identify the impact of metabolic surgery on the risk of follow-up CR, including
percutaneous coronary revascularization (PCI) and coronary artery bypass grafting
(CABG)
Setting
Stony Brook Department of Surgery, Stony Brook University Hospital, New York, United
States.
Methods
A retrospective analysis was performed for patients with obesity between 2006 and
September 2015. Patients were divided into those with history of metabolic surgery
and those without. Patient were also stratified by bariatric surgery type. All study
groups were followed till 2018 and for at least 3 years to monitor the development
of the primary endpoint—any CR including PCI or CABG.
Results
The study population with obesity was 515,307 patients; 95,901 with history of surgery
versus 419,406 matched patients without. A total of 12,873 (13.4%) with surgery and
51,478 (12.27%) without were lost to follow-up by 2018. The group with history of
surgery had a reduced risk of future CR (hazard ratio [HR], .46; 95% confidence interval
[CI]: .42–.50; P < .0001), PCI (HR, .45; 95% CI: .41–.49; P < .0001) and CABG (HR, .49; 95% CI:.42–.56; P < .0001). In subgroup analysis, laparoscopic adjustable gastric banding compared
with Roux-en-Y gastric bypass (RYGB) was associated with higher follow-up CR (HR,
1.34; 95% CI: 1.11–1.63; P < .01) and PCI (HR, 1.34; 95% CI: 1.07–1.68; P < .05).
Conclusion
Bariatric surgery is associated with reduced risk of future CR, PCI, and CABG. Upon
subgroup analysis, RYGB was associated with reduced risk of PCI and CR.
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgery for Obesity and Related DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure.J Am Heart Assoc. 2017; 6e005126
- Mechanisms linking obesity with cardiovascular disease.Nature. 2006; 444: 875-880
- Adiposopathy: is “sick fat” a cardiovascular disease?.J Am Coll Cardiol. 2011; 57: 2461-2473
- Adipocytes as regulators of energy balance and glucose homeostasis.Nature. 2006; 444: 847-853
- Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, the Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists - executive summary.Endocr Pract. 2019; 25: 1346-1359
- How much weight loss is required for cardiovascular benefits? insights from a metabolic surgery matched-cohort study.Ann Surg. 2020; 272: 639-645
- Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study.Eur Heart J. 2020; 41: 2660-2667
Brown AM, Yang J, Zhang X, Docimo S, Pryor AD, Spaniolas K. Bariatric surgery lowers the risk of major cardiovascular events. Ann Surg. Epub 2020 Nov 18.
- Effects of bariatric surgery on mortality in Swedish obese subjects.N Engl J Med. 2007; 357: 741-752
- Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity.JAMA. 2019; 322: 1271-1282
- Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity.JAMA. 2018; 320: 1570-1582
- Bariatric surgery reduces long-term rates of cardiac events and need for coronary revascularization: a propensity-matched analysis.Surg Endosc. 2020; 34: 2638-2643
- Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes.Eur Heart J. 2020; 41: 2747-2755
- Bariatric surgery and long-term durability of weight loss.JAMA Surg. 2016; 151: 1046-1055
- Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.Lancet. 2015; 386: 964-973
- Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery.Obesity (Silver Spring). 2007; 15: 772-784
- Bariatric surgery and long-term cardiovascular events.JAMA. 2012; 307: 56-65
- Long-term mortality after gastric bypass surgery.N Engl J Med. 2007; 357: 753-761
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014 Jun 24;129(25 Suppl 2):S102–S138.
- Heart disease and stroke statistics-2018 update: a report from the American Heart Association.Circulation. 2018; 137: e67-e492
- Obesity and cardiovascular disease: a scientific statement from the American Heart Association.Circulation. 2021; 143: e984-e1010
- Seven-year weight trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) study.JAMA Surg. 2018; 153: 427-434
- Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures.Am J Med. 2008; 121: 885-893
- Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.Int J Obes (Lond). 2009; 33: 786-795
- Comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass.JAMA Surg. 2020; 155e200087
- Socioeconomic status and cardiovascular outcomes: challenges and interventions.Circulation. 2018; 137: 2166-2178
Article info
Publication history
Published online: January 25, 2022
Accepted:
January 12,
2022
Received:
September 8,
2021
Identification
Copyright
© 2022 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Comment on: The impact of bariatric surgery on the risk of coronary revascularizationSurgery for Obesity and Related DiseasesVol. 18Issue 5
- PreviewWe read with great interest the study from Noubani et al. [1], which provides retrospective data on the impact of bariatric surgery on coronary revascularization, extracted from the New York State Statewide Planning and Research Cooperative System (SPARCS) database. The authors identified more than 500,000 patients with obesity (BMI >30 kg/m2) and compared those who had undergone bariatric surgery with those who had not. Patients were matched in a 1:5 ratio according to a range of variables. The primary outcome was coronary revascularization (CR), defined by percutaneous coronary intervention, coronary artery bypass grafting, or both.
- Full-Text
- Preview
